BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29217477)

  • 1. Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.
    Zhang W; Yang X; Chen Y; Hu W; Liu L; Zhang X; Liu M; Sun L; Liu Y; Yu M; Li X; Li L; Zhu Y; Miao QR; Han J; Duan Y
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):177-190. PubMed ID: 29217477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nogo-B receptor deficiency increases liver X receptor alpha nuclear translocation and hepatic lipogenesis through an adenosine monophosphate-activated protein kinase alpha-dependent pathway.
    Hu W; Zhang W; Chen Y; Rana U; Teng RJ; Duan Y; Liu Z; Zhao B; Foeckler J; Weiler H; Kallinger RE; Thomas MJ; Zhang K; Han J; Miao QR
    Hepatology; 2016 Nov; 64(5):1559-1576. PubMed ID: 27480224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatoprotective effect of the combination use of Fructus Schisandrae with statin--A preclinical evaluation.
    Wat E; Ng CF; Wong EC; Koon CM; Lau CP; Cheung DW; Fung KP; Lau CB; Leung PC
    J Ethnopharmacol; 2016 Feb; 178():104-14. PubMed ID: 26666731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin reduces lipid accumulation in the liver by activating protein kinase A-mediated phosphorylation of perilipin 5.
    Gao X; Nan Y; Zhao Y; Yuan Y; Ren B; Sun C; Cao K; Yu M; Feng X; Ye J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Dec; 1862(12):1512-1519. PubMed ID: 28919478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
    Im AR; Kim YH; Lee HW; Song KH
    J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.
    Vilà L; Rebollo A; Ađalsteisson GS; Alegret M; Merlos M; Roglans N; Laguna JC
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):32-40. PubMed ID: 21122807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins inhibited the MIP-1α expression via inhibition of Ras/ERK and Ras/Akt pathways in myeloma cells.
    Tsubaki M; Mashimo K; Takeda T; Kino T; Fujita A; Itoh T; Imano M; Sakaguchi K; Satou T; Nishida S
    Biomed Pharmacother; 2016 Mar; 78():23-29. PubMed ID: 26898421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
    Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
    Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of atorvastatin in suppressing MUC5AC gene expression in human airway epithelial cells.
    Lee EJ; Song KJ; Hwang HJ; Kim KS
    Int Forum Allergy Rhinol; 2016 Nov; 6(11):1159-1166. PubMed ID: 27310028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.
    Morishita S; Tomita K; Ono T; Murakoshi M; Saito K; Sugiyama K; Nishino H; Kato H
    Biochem Cell Biol; 2015 Dec; 93(6):566-73. PubMed ID: 26335364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
    Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
    Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice.
    Lin Q; Huang Z; Cai G; Fan X; Yan X; Liu Z; Zhao Z; Li J; Li J; Shi H; Kong M; Zheng MH; Conklin DJ; Epstein PN; Wintergerst KA; Mohammadi M; Cai L; Li X; Li Y; Tan Y
    Hepatology; 2021 Jun; 73(6):2206-2222. PubMed ID: 32965675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
    He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
    World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription cofactor CRTC1 protects from aberrant hepatic lipid accumulation.
    Kim H
    Sci Rep; 2016 Nov; 6():37280. PubMed ID: 27869139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
    Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of NgBR inhibits high-fat diet-induced atherosclerosis in ApoE-deficiency mice.
    Gong K; Wang M; Wang D; Gao Y; Ma L; Yang X; Zhu X; Chen S; Zhang M; Li H; Chen Y; Hu W; Miao QR; Iwakiri Y; Liao C; Duan Y; Han J
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36996002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
    Zhang M; Chi X; Qu N; Wang C
    Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
    Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO
    Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.
    Shyu KG; Wang BW; Chen WJ; Kuan P; Hung CR
    Eur J Heart Fail; 2010 Mar; 12(3):219-26. PubMed ID: 20156938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.